- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Degarelix – July 2010
DEGARELIX, powder for subcutaneous injection (modified release), 80 mg and 120 mg, (as acetate) with solvent, syringe and needles, Firmagon®
Last updated
29 October 2010